Understanding Your Mounjaro or Wegovy Treatment Options
Mounjaro or Wegovy: Key Prescription Weight Loss Differences
When comparing Mounjaro or Wegovy for prescription weight loss, the fundamental difference lies in their mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. Mounjaro contains tirzepatide, which targets both GIP and GLP-1 receptors, making it a dual agonist with a broader hormonal approach to weight management. Both are prescription-only medicines that require clinical assessment and must be used alongside a reduced-calorie diet and increased physical activity.
The choice between Mounjaro or Wegovy often comes down to individual response patterns and practical considerations. Wegovy has been available longer in the UK market and has extensive clinical trial data spanning multiple years, whilst Mounjaro represents newer dual-agonist technology. Both treatments require weekly injections and follow structured dose escalation protocols, though their specific dosing schedules differ. Your prescriber will consider your medical history, weight loss goals, and any existing conditions when recommending either option.
Mounjaro or Wegovy Pricing: Complete UK Cost Breakdown
Understanding the cost implications when choosing between Mounjaro or Wegovy helps inform your decision. Wegovy pricing at EverydayMeds starts from £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Bundle options include the Intro Duo (0.25mg & 0.5mg) at £169.99 and the Progress Trio (0.5mg, 1mg & 1.7mg) for £369.99. New customers can apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 to reach these final prices.
Mounjaro pricing follows a different structure reflecting its dual-agonist formulation, though both treatments represent significant investment in your weight management journey. When weighing Mounjaro or Wegovy costs, consider the complete treatment pathway rather than just initial doses, as both require several months to reach maintenance levels. Bundle options provide convenience of Reliable Supply and fewer individual orders, ensuring treatment continuity during your weight loss programme through our GPhC-registered pharmacy #9012878.
Clinical Evidence: Mounjaro or Wegovy Trial Results
The clinical evidence supporting Mounjaro or Wegovy demonstrates both treatments' efficacy in weight management programmes. Wegovy's STEP trials showed participants achieved average weight loss of approximately 15% at 68 weeks when combined with lifestyle interventions (Wilding et al., NEJM, 2021). The STEP programme included diverse populations, with STEP 2 showing 9.6% average weight loss in patients with type 2 diabetes, whilst STEP 3 demonstrated 16% average weight reduction with intensive behavioural therapy.
Mounjaro's SURMOUNT trials revealed the potential of dual GIP/GLP-1 agonism in weight management, though direct comparison between Mounjaro or Wegovy trial results requires careful consideration of different study designs and patient populations. Both treatments showed superior results compared to placebo when used alongside reduced-calorie diets and increased physical activity. Individual results may vary significantly, and sustainable weight management requires long-term commitment beyond the prescription-only medicine component.
How Wegovy Works: GLP-1 Mechanism Explained
Understanding how Wegovy functions helps clarify whether Mounjaro or Wegovy suits your needs better. Wegovy's semaglutide acts specifically on GLP-1 receptors in your brain's appetite control centres, mimicking the natural hormone that signals fullness after eating. This targeted action reduces hunger signals, promotes earlier satiety during meals, and may help reduce food cravings throughout the day. The once-weekly injection provides sustained GLP-1 receptor activation, maintaining appetite suppression between doses. Unlike rapid-acting appetite suppressants, Wegovy works gradually to reset your body's hunger and fullness responses, supporting portion control and healthier eating patterns when combined with nutritional guidance.
Starting Your Mounjaro or Wegovy Journey: Assessment Process
Beginning treatment with either Mounjaro or Wegovy through EverydayMeds involves a comprehensive 3-minute online clinical assessment covering your medical history, current medications, weight management goals, and previous diet attempts. Our registered prescribers review your application within 3 working days (or 24 hours with express service), ensuring both treatments are clinically appropriate for your circumstances. Once approved, your chosen prescription-only medicine ships via next-day cold-chain delivery, maintaining the strict temperature requirements essential for these injectable treatments. The assessment considers factors like BMI, weight-related comorbidities, and any contraindications that might influence whether Mounjaro or Wegovy is more suitable. Follow-up consultations ensure your treatment remains effective and well-tolerated throughout your weight management programme.
Storage and Practical Considerations: Mounjaro or Wegovy Differences
Practical storage requirements present notable differences when choosing between Mounjaro or Wegovy for long-term treatment. Wegovy offers superior travel flexibility, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both require refrigerated storage at 2-8°C before first use and utilize user-friendly injection pen devices for weekly administration. Wegovy's FlexTouch pen system provides clear dose confirmation and simplified injection technique, whilst both treatments follow structured dose escalation schedules that cannot be accelerated. The longer room temperature stability of Wegovy makes it particularly suitable for frequent travellers or those with unreliable refrigeration access, though both options remain viable for most patients' lifestyle requirements.
Choosing Between Mounjaro or Wegovy: Personalised Weight Loss Approach
The decision between Mounjaro or Wegovy ultimately depends on individual factors beyond just clinical efficacy data. Some patients may respond better to Wegovy's targeted GLP-1 action, whilst others might benefit from Mounjaro's broader dual-receptor approach. Your medical history, including any diabetes, cardiovascular conditions, or previous weight loss attempts, influences which treatment may be most appropriate. Both prescription-only medicines require similar lifestyle commitments and regular monitoring, though their side effect profiles and dose escalation schedules differ.
Working with experienced prescribers ensures your choice between Mounjaro or Wegovy aligns with your specific circumstances and weight management goals. Neither treatment ensures universal success, and both require patience as effects develop over several weeks of dose escalation. The most effective approach combines either medication with sustainable dietary changes, increased physical activity, and ongoing professional support throughout your weight management journey.
Order Your Prescribed Weight Loss Treatment Today
Both Mounjaro or Wegovy are available through EverydayMeds' streamlined ordering system, with new customers using discount code FIRST40 and returning customers applying DOSE25 at checkout to access our competitive pricing. Your chosen treatment begins with a thorough clinical assessment, ensuring prescription safety and appropriateness before any medication is dispensed. Our cold-chain delivery system maintains medication integrity from our GPhC-registered pharmacy directly to your door, supporting treatment success from the first injection. The comprehensive support continues throughout your weight management programme, with prescriber guidance available for dose adjustments, side effect management, and long-term treatment planning. Take the first step in your weight loss journey by completing our 3-minute assessment and discovering which option—Mounjaro or Wegovy—may be right for you.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
